Adhesion barriers are medical implants in the form of gels, films, or liquids that create a barrier to prevent adhesions from forming after surgery. These implants are made using substances like hyaluronic acid, polyethylene glycol, collagen, proteins, and fibrin. They are compatible with the body, do not trigger an immune response, have anti-inflammatory properties, break down naturally, are structurally strong, and degrade at a rate that aligns with tissue healing. By separating internal tissues and organs, they help reduce abnormal scarring inside the body. Currently, leading market players are developing sprayable adhesion barriers that are easy to use and can adapt to complex surfaces.

Adhesion Barriers Market Trends and Drivers:

The rising number of elderly individuals and the higher occurrence pelvic and abdominal issues, leading to a greater chance of post-surgery complications from various invasive treatments, are significant factors driving the global demand for adhesion barriers. The increasing use of adhesion barriers in gynecological, orthopedic, cardiovascular, urological, and reconstructive market expansion. Additionally, the thriving healthcare industry and the availability of cost-effective surgical options are fostering a favorable market environment. Furthermore, the rise in investments in research and development (R&D) efforts to integrate gene therapy for preventing post-surgery adhesion formation is expected to enhance market growth worldwide.

Top Adhesion Barriers Market Leaders:

Anika Therapeutics Inc.

Atrium Medical Corporation

Baxter International Inc.

Betatech Medical

C. R. Bard, Inc.

FzioMed Inc.

LifeSciences Corporation

Medical Devices Business Services Inc.

MAST Biosurgery Inc.

Groupe Sanofi

Request Sample For PDF Report: https://www.imarcgroup.com/adhesion-barriers-market/requestsample